PCM
Parsons Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.64M | Buy |
10,428
+2,660
| +34% | +$1.18M | 0.29% | 79 |
|
|
2025
Q1 | $3.77M | Buy |
7,768
+735
| +10% | +$356K | 0.21% | 100 |
|
|
2024
Q4 | $2.83M | Buy |
7,033
+1,521
| +28% | +$613K | 0.15% | 128 |
|
|
2024
Q3 | $2.56M | Buy |
5,512
+250
| +5% | +$116K | 0.16% | 135 |
|
|
2024
Q2 | $2.47M | Buy |
5,262
+2,591
| +97% | +$1.21M | 0.17% | 130 |
|
|
2024
Q1 | $1.12M | Buy |
2,671
+1,884
| +239% | +$788K | 0.08% | 220 |
|
|
2023
Q4 | $320K | Buy |
787
+100
| +15% | +$40.7K | 0.02% | 365 |
|
|
2023
Q3 | $239K | Hold |
687
| – | – | 0.02% | 383 |
|
|
2023
Q2 | $242K | Sell |
687
-2
| -0.3% | -$704 | 0.02% | 387 |
|
|
2023
Q1 | $217K | Buy |
+689
| New | +$217K | 0.02% | 398 |
|
|
2021
Q4 | – | Sell |
-1,268
| Closed | -$230K | – | 442 |
|
|
2021
Q3 | $230K | Sell |
1,268
-1,420
| -53% | -$258K | 0.02% | 401 |
|
|
2021
Q2 | $542K | Sell |
2,688
-723
| -21% | -$146K | 0.04% | 283 |
|
|
2021
Q1 | $733K | Sell |
3,411
-2,618
| -43% | -$563K | 0.06% | 236 |
|
|
2020
Q4 | $1.43M | Sell |
6,029
-70
| -1% | -$16.5K | 0.12% | 159 |
|
|
2020
Q3 | $1.66M | Buy |
6,099
+412
| +7% | +$112K | 0.16% | 129 |
|
|
2020
Q2 | $1.65M | Buy |
5,687
+345
| +6% | +$100K | 0.18% | 118 |
|
|
2020
Q1 | $1.27M | Buy |
+5,342
| New | +$1.27M | 0.16% | 132 |
|